After an increase in the deaths of children from alleged consumption of Coldrif cough syrup, the Directorate General of Health Services strongly ordered all states and Union Territories, directing them to conduct stricter testing of pharmaceutical products. The death toll from allegedly consuming Coldrif cough syrup has increased to 20. Madhya Pradesh, where initially and most deaths occurred, reported four new deaths in the last 24 hours. According to some reports, the investigations have revealed that some cough syrups, which were barred from being administered to children under four years of age, were still being sold.